Affinivax Patents – Key Insights and Stats

Affinivax has a total of 39 patents globally, out of which 16 have been granted. Of these 39 patents, more than 94% patents are active. United States of America is where Affinivax has filed the maximum number of patents, followed by Australia and Singapore. Parallelly, United States of America seems to be the main focused R&D centre of Affinivax.

Affinivax was founded in the year 2014 by Fan Zhang, George Siber, Richard Malley and Yingjie Lu. Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.

Do read about some of the most popular patents of Affinivax which have been covered by us in this article and also you can find Affinivax patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Affinivax patent portfolio.

How many patents does Affinivax have?

Affinivax has a total of 39 patents globally. These patents belong to 5 unique patent families. Out of 39 patents, 37 patents are active.

How Many Patents did Affinivax File Every Year?

Affinivax Patent Filling Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAffinivax Applications FiledAffinivax Patents Granted
2022– 4
20211012
20203 –
201914 –
201812 –

How many Affinivax patents are Alive/Dead?

Affinivax Patent Portfolio

How Many Patents did Affinivax File in Different Countries?

Affinivax Worldwide Patent Filling

Countries in which Affinivax File patents

CountriesPatents
United States Of America3
Australia2
Singapore2
Malaysia2
Canada2
Viet Nam2
China2
Israel2
Colombia2
Philippines2
Europe2
Brazil2
South Africa2
Hong Kong (S.A.R.)2
India2
Indonesia2
Mexico1
Chile1
Peru1
Taiwan1

Where are Research Centres of Affinivax Patents Located?

Research Centres of Affinivax Patents

List of Affinivax Patents

Affinivax PatentsTitle
BR112019027387A8IMMUNOGENIC compositions
EP3849587A4Multivalent pneumococcal vaccines
US20220072118A1Immunogenic compositions
PH12021550542A1Multivalent pneumococcal vaccines
VN82546APneumococcal Vaccination Pneumococcal VARIOUS, Immune Complex, Containing BIOTINYLIED POLYSACARIATE ANTI, PHARMACEUTICAL AND PHARMACEUTICAL CONTAINS AND METHODS FOR CREATION
HK40046980AMultivalent pneumococcal vaccines
US20210346487A1Multivalent pneumococcal vaccines
IN202117016515AMultivalent pneumococcal vaccines
CL202100608A1multivalent pneumococcal vaccines
ID2021PID07790AMultivalent pneumococcal vaccine
MX2021002910AMULTIVALENT PNEUMOCOCCAL VACCINES
CO20210004456A2multivalent pneumococcal vaccines
PE0011122021A1MULTIVALENT PNEUMOCOCCAL VACCINES
CN112969474AMultivalent pneumococcal vaccines
BR112021004193A2MULTIVALENT Pneumococcal vaccines
US11013793B2Multivalent pneumococcal vaccines
AU2019338473A1Multivalent pneumococcal vaccines
IL281204AMultivalent pneumococcal vaccines
ZA202101470AMultivalent pneumococcal vaccines
SG11202102007UAMultivalent pneumococcal vaccines
VN74087AImmune-Stimulating PHARMACEUTICAL PRODUCTS AND PHARMACEUTICAL CONTAINS
HK40021266AImmunogenic compositions
PH12019502915A1Immunogenic compositions
ID2020PID02559AIMUNOGENIC COMPOSITION
TW202019470AMultivalent pneumococcal vaccines
EP3641828A1Immunogenic compositions
CN111065417AImmunogenic compositions
CO20190014647A2immunogenic compositions
WO2020056202A1Multivalent pneumococcal vaccines
CA3111459A1Multivalent pneumococcal vaccines
MYPI2021001244A0Multivalent pneumococcal vaccines
AU2018290298A2Immunogenic compositions
IN202047002529AImmunogenic compositions
IL271603AImmunogenic compositions
SG11201912601RAImmunogenic compositions
ZA201908498AImmunogenic compositions
WO2018237221A1Immunogenic compositions
CA3067587A1Immunogenic compositions
MYPI2019007645A0Immunogenic compositions

What are Affinivax key innovation segments?

What Technologies are Covered by Affinivax?

The chart below distributes patents filed by Affinivax in different countries on the basis of the technology protected in patents. It also represents the markets where Affinivax thinks it’s important to protect particular technology inventions.

R&D Focus: How has Affinivax search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Affinivax?

Table of Content

Insights you may find interesting

Related Articles

Verily Patents – Insights & Stats (Updated 2024)

Verily has a total of 2401 patents globally, out of which 1313 have been granted. Of these 2401 patents, more than 60% patents are active. United States of America is where Verily has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States of America

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.